Polymorphism of Prolactin Secreted by Human Prolactinoma Cells: Immunological, Receptor Binding, and Biological Properties of the Glycosylated and Nonglycosylated Forms*
- 1 June 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 122 (6) , 2667-2674
- https://doi.org/10.1210/endo-122-6-2667
Abstract
Multiple forms of PRL differing in their physicochemical and biological characteristics have been described. We have analyzed the molecular forms of human (h) PRL released in culture by pure hPRL-secreting tumors with a particular attention to glycosylated hPRL. The prolactinoma cells from six different tumors released, in serum-free conditions, 10-28 mg hPRL. The combination of polyacrylamide gel electrophoresis and immunoblotting techniques using a [125I]anti-hPRL monoclonal antibody allowed qualitative and quantitative analysis of the hPRL variants. The ratio of the glycosylated 25,000-mol wt form (G-hPRL) to the 23,000-mol wt nonglycosylated monomeric hPRL (NG-hPRL) varied from 0.13 to 0.25. Under the conditions of our studies, cleaved forms of the hormone (19,000 and 15,000 mol wt) accounted for less than 5% of the total immunoreactivity. G- and NG-hPRL were subsequently purified by gel filtration and lectin affinity chromatography. G-hPRL appeared fully sensitive to endoglycosidase F digestion, further supporting the presence of a freely accessible N-linked carbohydrate chain. When assayed for their ability to react with polyclonal antibodies directed against hPRL in a competitive RI, G-hPRL was 3 times less immunoreactive than NG-hPRL. However, both types of hPRL exhibited superimposed displacement curves when tested in an immunoassay using an anti-hPRL monoclonal antibody. In binding studies using crude rabbit mammary gland membranes G-hPRL was half as potent as NG-hPRL. In stimulating the growth of the Nb2 lymphoma cell line, G-hPRL was 50% less active than NG-hPRL. Thus 1) under basal conditions, hPRL undergoes partial and variable glycosylation; 2) glycosylation of the hormone may modulate its immunoreactivity; 3) glycosylation of hPRL not only lowers its mammary gland receptor binding capacity but also its growth-promoting activity.This publication has 18 references indexed in Scilit:
- Glycosylated ovine prolactin.Proceedings of the National Academy of Sciences, 1984
- Role of carbohydrate in human chorionic gonadotropin. Effect of deglycosylation on the subunit interaction and on its in vitro and in vivo biological properties.Journal of Biological Chemistry, 1983
- Studies on pituitary follitropin X. Biochemical, receptor binding and immunological properties of deglycosylated ovine hormoneMolecular and Cellular Endocrinology, 1982
- A New Sensitive and Specific Bioassay for Lactogenic Hormones: Measurement of Prolactin and Growth Hormone in Human Serum*Journal of Clinical Endocrinology & Metabolism, 1980
- A METHOD FOR ISOLATION BY GEL ELECTROFOCUSING OF ISOHORMONES B AND C OF HUMAN PROLACTIN FROM AMNIOTIC FLUIDJournal of Endocrinology, 1980
- Receptor binding, biological, and immunological properties of chemically deglycosylated pituitary lutropinArchives of Biochemistry and Biophysics, 1979
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- HUMAN PITUITARY PROLACTIN (hPRL): THE ENTIRE LINEAR AMINO ACID SEQUENCEJournal of Clinical Endocrinology & Metabolism, 1977
- Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factorsExperimental Eye Research, 1977
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976